{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:46:10Z","timestamp":1790358370989,"version":"4.1.0"},"reference-count":43,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-14-0925","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T18:22:45Z","timestamp":1417544565000},"page":"381-390","source":"Crossref","is-referenced-by-count":68,"title":["Current Status of Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter Defibrillator in Patients With Chronic Heart Failure"],"prefix":"10.1253","volume":"79","author":[{"given":"Hiroyuki","family":"Satake","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Evidenced-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masateru","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhi","family":"Hasebe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Segawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"},{"name":"Department of Evidenced-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the CHART-2 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Epstein AE, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, et al. 2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Association Rhythm Society. <i>Circulation<\/i> 2012; 127: e283\u2013e352, doi:10.1161\/CIR.0b013e318276ce9b.","DOI":"10.1161\/CIR.0b013e318276ce9b"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. <i>Europace<\/i> 2006; 8: 746\u2013837.","DOI":"10.1093\/europace\/eul108"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011): Digest version. <i>Circ J<\/i> 2013; 77: 249\u2013274.","DOI":"10.1253\/circj.CJ-66-0054"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. <i>N Engl J Med<\/i> 2002; 346: 877\u2013883.","DOI":"10.1056\/NEJMoa013474"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. <i>N Engl J Med<\/i> 2005; 352: 225\u2013237.","DOI":"10.1056\/NEJMoa043399"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, et al. ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. <i>Circulation<\/i> 2008; 117: e350\u2013e408, doi:10.1161\/CIRCUALTIONAHA.108.189742.","DOI":"10.1161\/CIRCUALTIONAHA.108.189742"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. <i>N Engl J Med<\/i> 1999; 341: 1882\u20131890.","DOI":"10.1056\/NEJM199912163412503"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kadlish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. <i>N Engl J Med<\/i> 2004; 350: 2151\u20132158.","DOI":"10.1056\/NEJMoa033088"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia \u2013 AMIOVIRT. <i>J Am Coll Cardiol<\/i> 2003; 41: 1707\u20131712.","DOI":"10.1016\/S0735-1097(03)00297-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials. <i>JAMA<\/i> 2004; 292: 2874\u20132879.","DOI":"10.1001\/jama.292.23.2874"},{"key":"11","unstructured":"11. Tanno K, Miyoshi F, Watanabe N, Minoura Y, Kawamura M, Ryu S, et al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? <i>Circ J<\/i> 2005; 69: 19\u201322."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: Results from the HIJAMI-II registry. <i>Heart<\/i> 2009; 95: 216\u2013220.","DOI":"10.1136\/hrt.2008.145243"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: First report from the CHART-2 Study. <i>Circ J<\/i> 2011; 75: 823\u2013833.","DOI":"10.1253\/circj.CJ-11-0135"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, et al. Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: A report from the CHART-2 study. <i>Circ J<\/i> 2013; 77: 2318\u20132326.","DOI":"10.1253\/circj.CJ-13-0127"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sakata Y, Miyata S, Nochioka K, Miura M, Takada T, Tadaki S, et al. Gender differences in clinical characteristics, treatment and long-term outcome in patients with stage C\/D heart failure in Japan: A report from the CHART-2 study. <i>Circ J<\/i> 2014; 78: 428\u2013435.","DOI":"10.1253\/circj.CJ-13-1009"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Miura M, Sakata Y, Miyata S, Nochioka K, Takada T, Tadaki S, et al. Usefulness of combined risk stratification with heart rate and systolic blood pressure in the management of chronic heart failure: A report from the CHART-2 study. <i>Circ J<\/i> 2013; 77: 2954\u20132962.","DOI":"10.1253\/circj.CJ-13-0725"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yancy CW, Jessup M, Bozlurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA Guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. <i>Circulation<\/i> 2013; 128: 1810\u20131852.","DOI":"10.1161\/CIR.0b013e31829e8807"},{"key":"18","unstructured":"18. Olgin AE, Zipes DP. Ventricular tachycardia, ECG recognition. <i>In<\/i>: Braunwald E, editor. Heart disease, 7th edn. Philadelphia: Saunders, 2005; 841\u2013842."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kearney MT, Fox KA, Lee AJ, Brooksby WP, Shah AM, Flapan A, et al. Predicting sudden death in patients with mild to moderate chronic heart failure. <i>Heart<\/i> 2004; 90: 1137\u20131143.","DOI":"10.1136\/hrt.2003.021733"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: Results from the Assessment of Treatment with Lisinopril And Survival (ATLAS) trial. <i>Circulation<\/i> 2000; 102: 611\u2013616.","DOI":"10.1161\/01.CIR.102.6.611"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Moss AJ, Hall WJ, Cannom SC, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. <i>N Engl J Med<\/i> 1996; 335: 1933\u20131940.","DOI":"10.1056\/NEJM199612263352601"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shiba N, Shimokawa H. Chronic heart failure in Japan: Implications of the CHART studies. <i>Vasc Health Risk Manag<\/i> 2008; 4: 103\u2013113.","DOI":"10.2147\/vhrm.2008.04.01.103"},{"key":"23","unstructured":"23. CIBIS-II Investigators and Committees. The Cardiac Insufficiency BISoprolol study II (CIBIS-II): A randomised trial. <i>Lancet<\/i> 1999; 352: 9\u201313."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. <i>N Engl J Med<\/i> 1995; 80: 257\u2013266.","DOI":"10.1056\/NEJM199512213332503"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pitt B, Segal R, Martinez FA, Meurers G, Cowley A, Thomas I, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). <i>Lancet<\/i> 1997; 349: 747\u2013752.","DOI":"10.1016\/S0140-6736(97)01187-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. <i>N Engl J Med<\/i> 1999; 341: 709\u2013717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"27","unstructured":"27. Ushigome R, Sakata Y, Miyata S, Miura M, Takada T, Tadaki S, et al. Improved long-term prognosis of patients with dilated cardiomyopathy: A report from the CHART studies. <i>Circ J<\/i> 2014; 78(Suppl I): 549."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Greeberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML, et al. Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II). <i>J Am Coll Cardiol<\/i> 2004; 43: 1459\u20131465.","DOI":"10.1016\/j.jacc.2003.11.038"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Abildstrom SZ, Ottesen MM, Rask-Madsen C, Andersen PK, Rosthoj S, Torp-Pedersen C, et al. Sudden cardiovascular death following myocardial infarction: The importance of left ventricular systolic dysfunction and congestive heart failure. <i>Int J Cardiol<\/i> 2005; 104: 184\u2013189.","DOI":"10.1016\/j.ijcard.2004.12.014"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. <i>N Engl J Med<\/i> 2005; 352: 2581\u20132588.","DOI":"10.1056\/NEJMoa043938"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hoang A, Shen C, Zheng J, Taylor S, Groh WJ, Rosenman M, et al. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: A 2012 calculation for a midwestern health referral region. <i>Heart Rhythm<\/i> 2014; 11: 849\u2013855.","DOI":"10.1016\/j.hrthm.2014.02.019"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Parkash R, Sapp JL, Basta M, Doucette S, Thompson K, Gardner M, et al. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. <i>Circ Arrhythm Electrophysiol<\/i> 2012; 5: 706\u2013713.","DOI":"10.1161\/CIRCEP.112.970798"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. <i>JAMA<\/i> 2007; 298: 1525\u20131532.","DOI":"10.1001\/jama.298.13.1525"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Gravelin LM, Yuhas J, Remetz M, Radford M, Foley J, Lampert R. Use of screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. <i>Circ Cardiovasc Qual Outcomes<\/i> 2011; 4: 152\u2013156.","DOI":"10.1161\/CIRCOUTCOMES.110.956987"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Birnie DH, Sambell C, Johansen H, Williams K, Lemery R, Green MS, et al. Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest. <i>CMAJ<\/i> 2007; 177: 41\u201346.","DOI":"10.1503\/cmaj.060730"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Sadarmin PP, Wong KC, Rajappan K, Bashir Y, Betts TR. Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators. <i>Europace<\/i> 2014; 16: 1575\u20131579.","DOI":"10.1093\/europace\/euu054"},{"key":"37","unstructured":"37. Dagres N, Hindricks G. Risk stratification after myocardial infarction: Is left ventricular ejection fraction enough to prevent sudden cardiac death? <i>Eur Heart J<\/i> 2013; 34: 1964\u20131971."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Borleffs CJW, van Rees JB, van Welsenes GH, van der Velde ET, van Erven L, Bax JJ, et al. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients. <i>J Am Coll Cardiol<\/i> 2010; 55: 879\u2013885.","DOI":"10.1016\/j.jacc.2009.09.053"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Pedersen OD, Abildstrom SZ, Ottesen MM, Rask-Madsen C, Bagger H, Kober L, et al. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation\/flutter following acute myocardial infarction. <i>Eur Heart J<\/i> 2006; 27: 290\u2013295.","DOI":"10.1093\/eurheartj\/ehi629"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Grimm W, Glaveris C, Hoffmann J, Menz V, Muller HH, Hufnagel G, et al. Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour Holter electrocardiography. <i>Am Heart J<\/i> 2000; 140: 43\u201351.","DOI":"10.1067\/mhj.2000.107178"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Watanabe J, Shinozaki T, Shiba N, Fukahori K, Koseki Y, Karibe A, et al. Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. <i>Eur J Heart Fail<\/i> 2006; 8: 237\u2013242.","DOI":"10.1016\/j.ejheart.2005.08.003"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, et al. Risk stratification for primary implantation of cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. <i>J Am Coll Cardiol<\/i> 2008; 51: 288\u2013296.","DOI":"10.1016\/j.jacc.2007.08.058"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Carson P, Anand I, O\u2019Connor C, Jaski B, Steinberg J, Lwin A, et al. Mode of death in advanced heart failure: The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial. <i>J Am Coll Cardiol<\/i> 2005; 46: 2329\u20132334.","DOI":"10.1016\/j.jacc.2005.09.016"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/2\/79_CJ-14-0925\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T22:56:43Z","timestamp":1566082603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/2\/79_CJ-14-0925\/_article"}},"subtitle":["\u2013 A Report From the CHART-2 Study \u2013"],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-14-0925","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}